Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Author:
Funder
Merck
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference57 articles.
1. Glucose, blood pressure, and cardiovascular risk;Lleva;Circ Cardiovasc Qual Outcomes,2012
2. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis;Bethel;Lancet Diabetes Endocrinol,2018
3. Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials. Nutrition, metabolism, and cardiovascular diseases;Mannucci;Nutr Metabol Cardiovasc Dis,2020
4. Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: an updated meta-analysis and subgroup analysis of randomized controlled trials;Mannucci;Diabetes Obes Metabol,2020
5. Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials;Monami;Acta Diabetol,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Common ground on immune infiltration landscape and diagnostic biomarkers in diabetes-complicated atherosclerosis: an integrated bioinformatics analysis;Frontiers in Endocrinology;2024-07-31
2. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk;Atherosclerosis;2024-07
3. Does insulin therapy affect all-cause mortality? machine learning complements propensity score analysis in a pharmacoepidemiologic study of adult diabetic females in Barranquilla, Colombia;Journal of Diabetes, Metabolic Disorders & Control;2023-12-15
4. Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs;Cureus;2023-10-02
5. Clinical pharmacology of antidiabetic drugs: What can be expected of their use?;La Presse Médicale;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3